FDA Inspection 1050217 — Community Blood Center Of Greater Kansas City

Community Blood Center Of Greater Kansas City — FEI 1972933

The FDA completed an inspection of Community Blood Center Of Greater Kansas City on April 6, 2018 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 6, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kansas City, MO (United States)